|
|
| (209 intermediate revisions by 19 users not shown) |
| Line 1: |
Line 1: |
| {{AIDS}} | | __NOTOC__ |
| | {{AIDS}}{{About1|Human Immunodeficiency Virus (HIV)}} |
| | '''For patient information, click [[AIDS Patient Information|here]]''' |
|
| |
|
| {{Infobox_Disease | | | {{CMG}} "{{cv}}"; {{AE}} {{AL}}, {{Ammu}}, {{JH}}, {{TarekNafee}}, {{Marjan}}, {{Mohamed riad}} |
| Name = Acquired immunodeficiency syndrome (AIDS) |
| |
| Image = Red_Ribbon.svg |
| |
| Caption = The Red ribbon is a symbol for solidarity with HIV-positive people and those living with AIDS. |
| |
| Width = 200 |
| |
| DiseasesDB = 5938 |
| |
| ICD10 = {{ICD10|B|24||b|20}} |
| |
| ICD9 = {{ICD9|042}} |
| |
| ICDO = |
| |
| OMIM = |
| |
| MedlinePlus =|
| |
| MeshID =|
| |
| }} | |
| {| style="float: right; clear:right; margin: 0 0 0.5em 1em; padding: 0.5em; background: #fffff4; border: 1px solid #ddb; width: 250px; font-size:90%;" | | {| style="float: right; clear:right; margin: 0 0 0.5em 1em; padding: 0.5em; background: #fffff4; border: 1px solid #ddb; width: 250px; font-size:90%;" |
| |- | | |- |
| Line 29: |
Line 19: |
| '''STI/STD''': [[Sexually transmitted infection]]/disease | | '''STI/STD''': [[Sexually transmitted infection]]/disease |
| |} | | |} |
| | | {{SK}} Acquired immunodeficiency syndrome; acquired immune deficiency syndrome |
| '''For AIDS Patient Information click [[AIDS Patient Information|here]]'''
| |
| | |
| {{CMG}} | |
| | |
| ==[[AIDS overview|Overview]]== | | ==[[AIDS overview|Overview]]== |
| ==[[AIDS historical perspective|Historical perspective]]==
| |
|
| |
|
| ==[[AIDS epidemiology and demographics|Epidemiology & Demographics]]== | | ==[[AIDS historical perspective|Historical Perspective]]== |
| ==[[AIDS risk factors|Risk Factors]]==
| |
| ==[[AIDS natural history, complications, and prognosis|Natural history, Complications, and Prognosis]]==
| |
|
| |
|
| ==[[AIDS pathophysiology|Pathophysiology]]==
| |
| ==[[AIDS classification|Classification]]== | | ==[[AIDS classification|Classification]]== |
| ==[[AIDS causes|Causes of AIDS]]==
| |
| ==[[AIDS history and symptoms|History and Symptoms]]==
| |
| ==[[AIDS primary prevention|Primary Prevention]]==
| |
| ==[[AIDS medical therapy|Medical Therapy]]==
| |
|
| |
|
| ==Prognosis== | | ==[[AIDS pathophysiology|Pathophysiology]]== |
|
| |
|
| Without treatment, the net median survival time after infection with HIV is estimated to be 9 to 11 years, depending on the HIV subtype,<ref name=UNAIDS2007/> and the median survival rate after diagnosis of AIDS in resource-limited settings where treatment is not available ranges between 6 and 19 months, depending on the study.<ref>{{cite paper |title= Progression and mortality of untreated HIV-positive individuals living in resource-limited settings: update of literature review and evidence synthesis |author= Zwahlen M, Egger M |url=http://data.unaids.org/pub/Periodical/2006/zwahlen_unaids_hq_05_422204_2007_en.pdf |format=PDF |date=2006 |accessdate=2008-03-19 |version= UNAIDS Obligation HQ/05/422204}}</ref> In areas where it is widely available, the development of [[HAART]] as effective therapy for HIV infection and AIDS reduced the death rate from this disease by 80%, and raised the life expectancy for a newly-diagnosed HIV-infected person to about 20 years.<ref>{{cite journal |journal= Int J Dermatol |date=2007 |volume=46 |issue=12 |pages=1219–28 |title= Current status of HIV infection: a review for non-HIV-treating physicians |author= Knoll B, Lassmann B, Temesgen Z |pmid=18173512 |doi=10.1111/j.1365-4632.2007.03520.x |pmid=18173512}}</ref>
| | ==[[AIDS causes|Causes]]== |
| | [[Human Immunodeficiency Virus]] |
|
| |
|
| ===Economic impact=== | | ==[[AIDS differential diagnosis|Differentiating AIDS from other Diseases]]== |
| [[Image:Life expectancy in some Southern African countries 1958 to 2003.jpg|right|295px|thumb|Changes in life expectancy in some hard-hit African countries. | |
| {{legend-line|red solid 2px|Botswana}}{{legend-line|darkgreen solid 2px|Zimbabwe}}{{legend-line|blue solid 2px|Kenya}}{{legend-line|black solid 2px|South Africa}}{{legend-line|grey solid 2px|Uganda}}]]
| |
|
| |
|
| HIV and AIDS retard economic growth by destroying human capital.<ref name=Bell-et-al-2003/>
| | ==[[AIDS epidemiology and demographics|Epidemiology and Demographics]]== |
| Without proper [[nutrition]], health care and medicine that is available in developed countries, large numbers of people are falling victim to AIDS. They will not only be unable to work, but will also require significant medical care. The forecast is that this will likely cause a collapse of economies and societies in the region. In some heavily infected areas, the epidemic has left behind many orphans cared for by elderly grandparents.<ref name=Greener>{{cite book
| |
| | author =Greener R
| |
| | year = 2002
| |
| | title = State of The Art: AIDS and Economics
| |
| | chapter = AIDS and macroeconomic impact
| |
| | editor = S, Forsyth (ed.)
| |
| | pages = 49–55
| |
| | publisher = IAEN
| |
| }}</ref>
| |
|
| |
|
| The increased mortality in this region will result in a smaller skilled population and labor force.<ref name=Greener /> This smaller labor force will be predominantly young people, with reduced knowledge and work experience leading to reduced productivity. An increase in workers’ time off to look after sick family members or for sick leave will also lower productivity. Increased mortality will also weaken the mechanisms that generate human capital and investment in people, through loss of income and the death of parents.<ref name=Greener /> By killing off mainly young adults, AIDS seriously weakens the taxable population, reducing the resources available for public expenditures such as education and health services not related to AIDS resulting in increasing pressure for the state's finances and slower growth of the economy. This results in a slower growth of the tax base, an effect that will be reinforced if there are growing expenditures on treating the sick, training (to replace sick workers), sick pay and caring for AIDS orphans. This is especially true if the sharp increase in adult mortality shifts the responsibility and blame from the family to the government in caring for these orphans.<ref name=Greener />
| | ==[[AIDS risk factors|Risk Factors]]== |
| | |
| On the level of the household, AIDS results in both the loss of income and increased spending on healthcare by the household. The income effects of this lead to spending reduction as well as a substitution effect away from education and towards healthcare and funeral spending. A study in Côte d'Ivoire showed that households with an HIV/AIDS patient spent twice as much on medical expenses as other households.<ref name=WBank>{{
| |
| | |
| cite journal |
| |
| author=Over M |
| |
| title=The macroeconomic impact of AIDS in Sub-Saharan Africa, Population and Human Resources Department |
| |
| journal=The World Bank | year=1992
| |
| | |
| }}</ref>
| |
| | |
| UNAIDS, WHO and the United Nations Development Programme have documented a correlation between the decreasing life expectancies and the lowering of gross national product in many African countries with prevalence rates of 10% or more. Indeed, since 1992 predictions that AIDS would slow economic growth in these countries have been published. The degree of impact depended on assumptions about the extent to which illness would be funded by savings and who would be infected.<ref name=WBank /> Conclusions reached from models of the growth trajectories of 30 sub-Saharan economies over the period 1990–2025 were that the economic growth rates of these countries would be between 0.56 and 1.47% lower. The impact on gross domestic product (GDP) per capita was less conclusive. However, in 2000, the rate of growth of Africa's per capita GDP was in fact reduced by 0.7% per year from 1990–1997 with a further 0.3% per year lower in countries also affected by [[malaria]].<ref name=Bonnel>{{
| |
| | |
| cite journal |
| |
| author=Bonnel R |
| |
| title=HIV/AIDS and Economic Growth: A Global Perspective |
| |
| journal=S. A. J. Economics | year=2000 | pages=820–855 | volume=68 | issue=5 |
| |
| | |
| }}</ref> The forecast now is that the growth of GDP for these countries will undergo a further reduction of between 0.5 and 2.6% per annum.<ref name=Greener /> However, these estimates may be an underestimate, as they do not look at the effects on output per capita.<ref name=Bell-et-al-2003>{{
| |
| | |
| cite paper
| |
| |author= Bell C, Devarajan S, Gersbach H |date=2003
| |
| |url=http://ssrn.com/abstract=636571
| |
| | title=The long-run economic costs of AIDS: theory and an application to South Africa
| |
| |accessdate= 2008-03-12
| |
| |version= World Bank Policy Research Working Paper No. 3152
| |
| | |
| }}</ref>
| |
| | |
| Many governments in sub-Saharan Africa denied that there was a problem for years, and are only now starting to work towards solutions. Underfunding is a problem in all areas of HIV prevention when compared to even conservative estimates of the problems.
| |
| | |
| Recent research by the Overseas Development Institute (ODI) has suggested that the private sector has begun to recognize the impact of HIV/AIDS on the bottom line, both directly and indirectly. It is estimated that a company can generate an average return of US$3 for every US$1 invested in employee health due to a reduced absenteeism, better productivity and reduction in employee turnover.<ref>{{cite journal
| |
| | author = Goetzel RZ, Ozminkowski RJ, Baase CM, Billotti GM
| |
| | title = Estimating the return-on-investment from changes in employee health risks on the Dow Chemical Company’s health care costs
| |
| | journal = Journal of Occupational and Environmental Medicine
| |
| | volume = 47
| |
| | year = 2005
| |
| | pages = 759-68
| |
| | pmid = 16093925}}</ref> Indirectly there are also important implications on the supply chain. Many multi-national corporations (MNCs) have therefore gotten involved in HIV/AIDS initiatives of three main types: a community-based partnerships, supply chain support, and sector-based initiatives.<ref name="odi">{{cite web |url=http://www.odi.org.uk/publications/briefing/bp_hiv_privatesector_nov07.pdf |format=PDF|title= AIDS and the private sector: The case of South Africa |accessyear=2007 |year=2007 |publisher=Overseas Development Institute}}</ref>
| |
| | |
| The launching of the world's first official HIV/AIDS Toolkit in Zimbabwe on October 3 2006 is a product of collaborative work between the International Federation of Red Cross and Red Crescent Societies, World Health Organization and the Southern Africa HIV/AIDS Information Dissemination Service. It is for the strengthening of people living with HIV/AIDS and nurses by minimal external support. The package, which is in form of eight modules focusing on basic facts about HIV and AIDS, was pre-tested in Zimbabwe in March 2006 to determine its adaptability. It disposes, among other things, categorized guidelines on clinical management, education and counseling of AIDS victims at community level.<ref name=xinhua>{{
| |
| | |
| cite web
| |
| | author=Mu Xuequan | publisher=xinhua | year= 2006
| |
| | url=http://news.xinhuanet.com/english/2006-10/04/content_5167991.htm
| |
| | title=Zimbabwe launches world's first AIDS training package
| |
| | accessdate = 2006-10-03
| |
| | |
| }}</ref>
| |
| | |
| The Copenhagen Consensus is a project that seeks to establish priorities for advancing global welfare using methodologies based on the theory of welfare economics. The participants are all economists, with the focus of the project being a rational prioritization based on economic analysis. The project is based on the contention that, in spite of the billions of dollars spent on global challenges by the United Nations, the governments of wealthy nations, foundations, charities, and non-governmental organizations, the money spent on problems such as malnutrition and climate change is not sufficient to meet many internationally-agreed targets. The highest priority was assigned to implementing new measures to prevent the spread of HIV and AIDS. The economists estimated that an investment of $27 billion could avert nearly 30 million new infections by 2010.<ref name=Kaiserfunds>{{
| |
| | |
| cite web
| |
| | publisher=kaisernetwork.org | year= 2002
| |
| | url=http://kaisernetwork.org/aids2002/syndication.asp?show=daily_report_1.html
| |
| | title=$27 Billion Boost for HIV Prevention Programs Could Avert Majority of Projected HIV Infections Worldwide
| |
| | accessdate = 2008-03-10
| |
| | |
| }}</ref>
| |
| | |
| ===Stigma===
| |
| [[Image:Saigon AIDS Sign.jpg|thumb|250px|right|AIDS Awareness Sign. Ho Chi Minh City, Vietnam (August 2005).]]
| |
| AIDS stigma exists around the world in a variety of ways, including ostracism, rejection, discrimination and avoidance of HIV infected people; compulsory HIV testing without prior [[consent]] or protection of confidentiality; violence against HIV infected individuals or people who are perceived to be infected with HIV; and the [[quarantine]] of HIV infected individuals.<ref name=UNAIDS2006Ch4>{{
| |
| | |
| cite book
| |
| | publisher =[[Joint United Nations Programme on HIV/AIDS|UNAIDS]]
| |
| | year = 2006
| |
| | title = 2006 Report on the global AIDS epidemic
| |
| | chapter = The impact of AIDS on people and societies
| |
| | chapterurl = http://data.unaids.org/pub/GlobalReport/2006/2006_GR_CH04_en.pdf
| |
| | accessdate = 2006-06-14
| |
| | format= PDF
| |
|
| |
|
| }}</ref> Stigma-related violence or the fear of violence prevents many people from seeking HIV testing, returning for their results, or securing treatment, possibly turning what could be a manageable chronic illness into a death sentence and perpetuating the spread of HIV.<ref name=Ogden>{{
| | ==[[AIDS screening|Screening]]== |
|
| |
|
| cite web
| | ==[[AIDS natural history, complications, and prognosis|Natural History, Complications and Prognosis]]== |
| | author =Ogden J, Nyblade L
| |
| | publisher = [[International Center for Research on Women]] | year = 2005 | title = Common at its core: HIV-related stigma across contexts | url = http://www.icrw.org/docs/2005_report_stigma_synthesis.pdf | format = PDF | accessdate = 2007-02-15
| |
|
| |
|
| }}</ref>
| | ==[[HIV Opportunistic Infections]]== |
|
| |
|
| AIDS stigma has been further divided into the following three categories:
| | ==[[HIV Coinfections]]== |
|
| |
|
| # Instrumental AIDS stigma—a reflection of the fear and apprehension that are likely to be associated with any deadly and transmissible illness.<ref name=Herek1999>{{
| | ==[[HIV and pregnancy|HIV and Pregnancy]]== |
|
| |
|
| cite journal
| | ==[[HIV infection in infants|HIV Infection in Infants]]== |
| | author=Herek GM, Capitanio JP | journal=American Behavioral Scientist | year=1999
| |
| | url=http://psychology.ucdavis.edu/rainbow/html/abs99_sp.pdf
| |
| | format= PDF
| |
| | title=AIDS Stigma and sexual prejudice
| |
| | accessdate = 2006-03-27
| |
| | volume=42
| |
| | issue=7
| |
| | pages=1130-1147
| |
| | doi=10.1177/0002764299042007006
| |
|
| |
|
| }}</ref>
| | ==[[Cardiac diseases in AIDS| HIV and Cardiovascular System]]== |
| # Symbolic AIDS stigma—the use of HIV/AIDS to express attitudes toward the social groups or lifestyles perceived to be associated with the disease.<ref name=Herek1999 />
| |
| # Courtesy AIDS stigma—stigmatization of people connected to the issue of HIV/AIDS or HIV- positive people.<ref name=Snyder>{{
| |
|
| |
|
| cite journal |
| | ==[[AIDS diagnosis|Diagnosis]]== |
| author=Snyder M, Omoto AM, Crain AL |
| | [[AIDS history and symptoms|History and Symptoms]] | [[AIDS physical examination|Physical Examination]] | [[AIDS laboratory findings|Laboratory Findings]] | [[AIDS electrocardiogram|Electrocardiogram]] | [[AIDS chest x ray|Chest X Ray]] | [[AIDS CT|CT]] | [[AIDS MRI|MRI]] | [[AIDS echocardiography|Echocardiography]] |
| title=Punished for their good deeds: stigmatization for AIDS volunteers |
| |
| journal=American Behavioral Scientist | year=1999 | pages=1175–1192 | volume=42 | issue=7 | doi=10.1177/0002764299042007009
| |
|
| |
|
| }}</ref>
| | ==Treatment== |
| | [[AIDS medical therapy|Medical Therapy]] | [[AIDS medical therapy|Nutrition]] | [[AIDS medical therapy|Drug-resistant]] | [[AIDS surgery|Surgery]] | [[AIDS primary prevention|Primary Prevention]] | | [[AIDS secondary prevention|Secondary Prevention]] | [[AIDS cost-effectiveness of therapy|Cost-Effectiveness of therapy]] | [[AIDS future or investigational therapies|Future or Investigational Therapies]] |
|
| |
|
| Often, AIDS stigma is expressed in conjunction with one or more other stigmas, particularly those associated with [[homosexuality]], bisexuality, promiscuity, and [[Intravenous drug use (recreational)|intravenous drug use]].
| | ==Case Studies== |
| | [[AIDS case study one|Case #1]] |
|
| |
|
| In many developed countries, there is an association between AIDS and homosexuality or bisexuality, and this association is correlated with higher levels of sexual prejudice such as anti-homosexual attitudes.<ref name=Herek2002>{{cite journal
| | ==Related Chapters== |
| |author=Herek GM, Capitanio JP, Widaman KF
| | * [[HIV infection in infants|HIV Infection in Infants]] |
| |title=HIV-related stigma and knowledge in the United States: prevalence and trends, 1991-1999 | | * [[HIV infected adolescents|HIV Infected Adolescents]] |
| |journal=Am J Public Health | | * [[AIDS defining clinical condition|AIDS defining Clinical Condition]] |
| |volume=92 | | * [[AIDS dementia complex|AIDS Dementia Complex]] |
| |issue=3 | | * [[AIDS-related lymphoma|AIDS-related Lymphoma]] |
| |pages=371–7 | | * [[AIDS education and training centers|AIDS Education and Training Centers]] |
| |year=2002 | | * [[AIDS-related complex|AIDS-related Complex]] |
| |pmid=11867313 | | *[[HIV pediatric classification system]] |
| |doi=
| | *[[HIV and AIDS misconceptions]] |
| |url=http://psychology.ucdavis.edu/rainbow/html/ajph2002.pdf
| | *[[Criminal transmission of HIV]] |
| |accessdate=2008-03-10
| |
| }}</ref> There is also a perceived association between AIDS and all male-male sexual behavior, including sex between uninfected men.<ref name=Herek1999/>
| |
|
| |
|
| ==References==
| | ==Further Reading== |
| {{reflist|3}}
| |
| | |
| ==Further reading== | |
| *{{cite web | | *{{cite web |
| |url=http://data.unaids.org/pub/EPISlides/2007/2007_epiupdate_en.pdf | | |url=http://data.unaids.org/pub/EPISlides/2007/2007_epiupdate_en.pdf |
| Line 251: |
Line 130: |
| }} | | }} |
|
| |
|
| ==External links== | | ==External Links== |
| * {{Dmoz|Health/Conditions_and_Diseases/Immune_Disorders/Immune_Deficiency/AIDS/|HIV/AIDS}}
| |
| * {{cite web
| |
| |url=http://aidsinfo.nih.gov/
| |
| |title=AIDSinfo - HIV/AIDS Treatment Information
| |
| |accessdate=2008-03-21
| |
| |publisher=US Department of Health and Human Services
| |
| |format=
| |
| |work=
| |
| }}
| |
| * {{cite web | | * {{cite web |
| |url=http://www.unaids.org/en/ | | |url=http://www.unaids.org/en/ |
| Line 269: |
Line 139: |
| |work= | | |work= |
| }} | | }} |
| {{AIDS}}
| | |
| {{Viral diseases}} | | [[AIDS#top|back to top]] |
| {{STD/STI}} | | |
| | {{WH}} |
| | {{WS}} |
|
| |
|
| [[Category:HIV/AIDS]] | | [[Category:HIV/AIDS]] |
| | [[Category:Disease]] |
| [[Category:Immune system disorders]] | | [[Category:Immune system disorders]] |
| [[Category:Infectious disease]] | | [[Category:Viral diseases]] |
| [[category:viral diseases]]
| |
| [[Category:Pandemics]] | | [[Category:Pandemics]] |
| [[Category:Sexually transmitted infections]] | | [[Category:Sexually transmitted infections]] |
| Line 283: |
Line 155: |
| [[Category:AIDS origin hypotheses]] | | [[Category:AIDS origin hypotheses]] |
| [[Category:Medical disasters]] | | [[Category:Medical disasters]] |
| [[Category:Acronyms]]
| |
| [[Category:Immunodeficiency]] | | [[Category:Immunodeficiency]] |
| [[Category:Microbiology]] | | [[Category:Microbiology]] |
| [[Category:Overview complete]] | | [[Category:Emergency mdicine]] |
| | | [[Category:Up-To-Date]] |
| {{Link FA|he}}
| | [[Category:Infectious disease]] |
| {{Link FA|vi}}
| |
| [[af:Vigs]]
| |
| [[als:AIDS]]
| |
| [[am:ኤድስ]]
| |
| [[an:SIDA]]
| |
| [[ar:متلازمة العوز المناعي المكتسب]]
| |
| [[ast:SIDA]]
| |
| [[az:QİÇS]]
| |
| [[bat-smg:AIDS]] | |
| [[be-x-old:СНІД]]
| |
| [[bg:Синдром на придобитата имунна недостатъчност]]
| |
| [[bm:Sida]]
| |
| [[bn:এইডস]] | |
| [[bs:Sida]]
| |
| [[ca:SIDA]]
| |
| [[cs:AIDS]]
| |
| [[da:Aids]]
| |
| [[de:Aids]]
| |
| [[dv:އެއިޑްސް ބަލި]]
| |
| [[el:AIDS]]
| |
| [[eo:Aidoso]]
| |
| [[es:SIDA]]
| |
| [[et:AIDS]]
| |
| [[eu:Hartutako Immuno Eskasiaren Sindromea]]
| |
| [[fa:ایدز]]
| |
| [[fi:AIDS]]
| |
| [[fr:Syndrome d'immunodéficience acquise]]
| |
| [[fur:AIDS]]
| |
| [[ga:SEIF]]
| |
| [[gd:AIDS]]
| |
| [[gl:SIDA]]
| |
| [[gu:એડ્સ]]
| |
| [[he:איידס]]
| |
| [[hi:एड्स]]
| |
| [[hr:Sindrom stečene imunodeficijencije]]
| |
| [[ht:Sida]]
| |
| [[hu:AIDS]]
| |
| [[hy:ՁԻԱՀ]]
| |
| [[id:AIDS]]
| |
| [[is:Alnæmi]]
| |
| [[it:AIDS]]
| |
| [[ja:後天性免疫不全症候群]]
| |
| [[ka:შიდსი]]
| |
| [[ki:AIDS]]
| |
| [[km:ជំងឺអេដស៍]]
| |
| [[kn:ಏಡ್ಸ್ ರೋಗ]]
| |
| [[ko:에이즈]]
| |
| [[ku:AIDS]]
| |
| [[la:SCDI]]
| |
| [[lb:Aids]]
| |
| [[ln:Sida]]
| |
| [[lo:ເອດສ໌]]
| |
| [[lt:AIDS]]
| |
| [[lv:AIDS]]
| |
| [[mk:СИДА]]
| |
| [[ml:എയ്ഡ്സ്]]
| |
| [[mn:Дархлалын олдмол хомсдол]]
| |
| [[mr:एड्स]]
| |
| [[ms:AIDS]]
| |
| [[mt:AIDS]]
| |
| [[new:एड्स]]
| |
| [[nl:Aids]]
| |
| [[nn:Hiv/aids]]
| |
| [[no:Aids]]
| |
| [[oc:SIDA]]
| |
| [[pl:Zespół nabytego niedoboru odporności]]
| |
| [[ps:اېډز]]
| |
| [[pt:Síndrome da imunodeficiência adquirida]]
| |
| [[qu:Unquy hark'aypa chaskisqa waqlliynin]]
| |
| [[ro:SIDA]]
| |
| [[ru:Синдром приобретённого иммунного дефицита]]
| |
| [[scn:AIDS]]
| |
| [[sh:AIDS]]
| |
| [[si:ඒඩ්ස්]]
| |
| [[simple:AIDS]]
| |
| [[sk:Aids]]
| |
| [[sl:Aids]]
| |
| [[sr:Сида]]
| |
| [[sv:Aids]]
| |
| [[sw:Ukimwi]]
| |
| [[ta:எய்ட்ஸ்]]
| |
| [[te:ఎయిడ్స్]]
| |
| [[tg:СПИД]]
| |
| [[th:เอดส์]]
| |
| [[tr:AIDS]]
| |
| [[tt:AİDS]]
| |
| [[uk:СНІД]]
| |
| [[ur:محصولی کسرمناعی متلازمہ]]
| |
| [[uz:Orttirilgan Imunitet Tanqisligi Sindromi]]
| |
| [[vec:AIDS]]
| |
| [[vi:AIDS]]
| |
| [[yi:עידס]]
| |
| [[yo:AIDS]]
| |
| [[zh:艾滋病]]
| |
| [[zh-min-nan:AIDS]]
| |
| [[zh-yue:愛滋病]]
| |
| | |
| | |
| {{WikiDoc Help Menu}}
| |
| {{WikiDoc Sources}}
| |